Navigation Links
New Clinical Studies Confirm Mauna Kea Technologies' Cellvizio(R) GI in Range of Procedures
Date:10/30/2007

- Data from five studies presented at United European Gastroenterology Week

(UEGW) - - Non-invasive imaging system diagnoses histology and pathology of the

gastrointestinal tract safely and effectively -

PARIS, Oct. 30 /PRNewswire/ -- Mauna Kea Technologies (MKT), the leader in the field of in vivo cellular imaging, announced that leading European gastroenterologists presented five abstracts related to the company's Cellvizio(R) GI at the 15th United European Gastroenterology Week (UEGW). The reported data demonstrate the clinical utility of Cellvizio(R) GI during double-balloon enteroscopy (DBE) as well as in the diagnosis of a range of gastrointestinal (GI) disorders. The findings also provide insight into criteria for optimizing Cellvizio(R) GI performance. The UEGW meeting is taking place in Paris October 27th - 31st .

Cellvizio(R) GI is the first and only confocal endomicroscopy instrument that is compatible with all endoscopes and allows real-time, dynamic microscopic imaging of the entire GI tract at 12 frames per second. To date, more than 600 patients have undergone an endoscopic procedure with the Cellvizio(R) GI imaging system.

Cellvizio and Double-Balloon Enteroscopy

In an oral presentation (Abstract FP-337), Pr. Stephan Miehlke, University Hospital, Dresden, Germany, described the first use of the Cellvizio(R) GI system with DBE to evaluate the entire small bowel in 27 procedures in 16 patients. Cellvizio(R) obtained informative images in all procedures but one, yielding a technical success rate of 96%. There were no adverse events related to DBE or the use of Cellvizio(R). The Cellvizio(R) system was able to detect both normal and abnormal villi throughout the GI tract. All Cellvizio(R) GI results were confirmed by subsequent histology of biopsy samples.

"The ability to use Cellvizio(R) GI with DBE provides a powerful new approach to evaluate the entire small bowel
'/>"/>

SOURCE Mauna Kea Technologies
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 Persistence Market Research ... Market Study on Ophthalmic Devices: Asia ... devices market was valued at USD 29,171.5 million in 2014 ... 6.5% from 2014 to 2020, to reach an estimated ... Browse the full Global Market Study on Ophthalmic Devices:  ...
(Date:9/22/2014)... Sept. 22, 2014  Neuralstem, Inc. (NYSE MKT: CUR) announced ... at Emory University, presented long-term follow up data on ... cells in the treatment of amyotrophic lateral sclerosis (ALS ... occurred at the Annual Symposium on ALS of the ... on Friday, and was not open to the public, ...
(Date:9/22/2014)... 22, 2014  For many people experiencing issues ... facing the prospect of large, painful incisions and ... activities are also impacted, such as working, driving ... the problem, some patients even delay necessary treatment, ... lead to permanent damage for some conditions. ...
Breaking Medicine Technology:Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 2Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 4Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 5Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 3Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 4Phoenix Arizona Hand Doctor Develops Revolutionary New Surgery System, Eliminates Need for Large Incisions 2
... SAN MATEO, Calif., June 10 /PRNewswire-FirstCall/ - NeurogesX, ... on developing and,commercializing novel pain management therapies, announced ... lead product candidate, NGX-4010, in the,journal Neurology. The ... Treatment of Painful HIV,Neuropathy," will appear in the ...
... open-label study presented ... at ... AMLN ) today announced data showing that the use of ... in more patients achieving diabetes treatment goals of,improved glucose control without ...
Cached Medicine Technology:NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology 2NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology 3Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 2Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 3Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 4Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 5
(Date:9/22/2014)... 22, 2014 The Philadelphia 100, which ... Philadelphia region each year, is considered a hallmark of ... MK Precision is proud to announce it has earned ... Precision will attend the Philadelphia 100 awards ... premiere business events of the year, as well as ...
(Date:9/22/2014)... MONDAY, Sept. 22, 2014 (HealthDay News) -- Teens and ... undergo "intensive" behavioral counseling to help prevent risky sexual ... Services Task Force. Every year, about 20 million ... occur in the United States. About half involve people ... task force. Its new report, published Sept. ...
(Date:9/22/2014)... New York, New York (PRWEB) September 22, 2014 ... ) filed against Boston Scientific Corp. continue to ... underway in U.S. District Court, Southern District of ... court documents, a new Docket Control Order was ... addresses a number of matters pertaining to the ...
(Date:9/22/2014)... Steven Reinberg HealthDay Reporter ... are urging that all children aged 6 months and older ... Academy of Pediatrics updated their influenza vaccine recommendations to advise ... vaccine to build immunity. The AAP also wants parents of ... the nasal spray vaccine instead of the flu shot if ...
(Date:9/22/2014)... whole eye transplant seems futuristic, if not impossible. ... Department of Defense, researchers at University of California, ... make implantation of an entire, functional eye a ... a holy grail for vision restoration," said Jeffrey ... co-recipient with colleagues at University of Pittsburg Medical ...
Breaking Medicine News(10 mins):Health News:MK Precision Announces Spot on Philadelphia 100 Fastest Growing Companies 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 3Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 4Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 2Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 3Health News:Looking ahead: Whole eye transplant under development 2
... (AMA) announced today the election of practicing Oklahoma,neonatal-perinatal ... Board of Trustees. In this position, Dr. McCaffree ... to ensure that all patients have access,to quality ... honor to serve physicians and patients,continuing our AMA ...
... After studying current,research, the American Medical Association (AMA) today ... more to obesity than other,caloric sweeteners, but called for ... of high fructose syrup and other sweeteners., "At ... use of,high fructose syrup or label products that contain ...
... American Medical,Association (AMA), the nation,s largest physician group, ... following new policies., APPROPRIATE ASPIRIN USE FOR ... more than 95,000 adult men and women, have ... of heart attack and stroke. The AMA,today passed ...
... alternative that won,t burden patients, workers, SUN ... which filed for bankruptcy protection in December, wants ... to ease its continued,financial troubles. However, caregivers are ... At a rally, workers will unveil their plan,to ...
... Healthation CEO Scott Kornhauser,announced the appointment of ... today. Mr. Hebert was a former consulting partner ... complex solutions in the healthcare,industry., Mr. Hebert,s ... and growing market share for Healthation. Prior to,joining ...
... doctor,s price to the regional, state, or ... nationwide ... today on their website, http://www.alijor.com . Users can now view,price ... a Provider" feature, patients can compare prices for,consultations, appointments, and follow ...
Cached Medicine News:Health News:AMA Adopts New Policies at Annual Meeting 2Health News:Hospital Workers Say Concessions Will Diminish Patient Care 2
... Graham-Field has been developing diverse ... 58 years. Our medical-surgical products ... for innovation, quality and customer ... include the Labtron® line of ...
... spill-proof design and effective output, even when ... medical nebulizers are free-standing for easy preparation., ... available., ,All Portex® medication nebulizer products ... feature consistently fine misting and the efficient ...
... a spill-proof design and effective output, even ... All medical nebulizers are free-standing for easy ... are available., ,All Portex® medication nebulizer ... nebulizers feature consistently fine misting and the ...
... with metered dose inhalers., ,ACE ensures ... MDI canisters. Its versatile design allows it ... in conjunction with an endotracheal airway or ... ACE may also be used in conjunction ...
Medicine Products: